Philippines expects approval of Covid-19 vaccine in the second quarter of 2021

Filipino health authorities said the new Russian Covid-19 vaccine and up to eight other vaccines against the disease could be approved between April and June next year if there are no delays in the clinical trials.

This stands in contrast to earlier remarks by President Rodrigo Duterte that a vaccine would be available for broad use already in December 2020.

According to health undersecretary Maria Rosario Vergeire, who spoke in a virtual media conference, the second quarter 2021 was a “practical and realistic” timeline, Reuters reported.

In detail, November or December 2020 will see the earliest conclusion of phase three trials of the vaccines, while from January to March 2021, the Philippine Food and Drug Administrations could approve the effective ones among them for distribution, based on their assessment of the phase three trials. From April to June 2021, the approved vaccines could be ready for local distribution.

Currently, the Department of Health is waiting for the clinical trial protocol for the vaccine called “Sputnik V” from Russia before it starts its evaluation for the conduct of clinical trials in the Philippines.

Shortened approval process time envisaged

Health officials already discussed the regulatory process with the Russian Embassy in Manila. They have committed to shorten the clearance process from 55 days to about 43 days once the requirements are complete, Vergeire said.

Besides the Russian vaccine, other candidates are vaccines developed in China, among other countries, that the Philippines will evaluate for use against the coronavirus. There is also a domestic vaccine development ongoing.

The Philippines is particularly plagued by the disease. As of September 21, the country has seen more than 290,000 infections, the most in Southeast Asia, with 230,000 recovered cases and 4,999 deaths.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

Filipino health authorities said the new Russian Covid-19 vaccine and up to eight other vaccines against the disease could be approved between April and June next year if there are no delays in the clinical trials. This stands in contrast to earlier remarks by President Rodrigo Duterte that a vaccine would be available for broad use already in December 2020. According to health undersecretary Maria Rosario Vergeire, who spoke in a virtual media conference, the second quarter 2021 was a “practical and realistic” timeline, Reuters reported. In detail, November or December 2020 will see the earliest conclusion of phase three...

Filipino health authorities said the new Russian Covid-19 vaccine and up to eight other vaccines against the disease could be approved between April and June next year if there are no delays in the clinical trials.

This stands in contrast to earlier remarks by President Rodrigo Duterte that a vaccine would be available for broad use already in December 2020.

According to health undersecretary Maria Rosario Vergeire, who spoke in a virtual media conference, the second quarter 2021 was a “practical and realistic” timeline, Reuters reported.

In detail, November or December 2020 will see the earliest conclusion of phase three trials of the vaccines, while from January to March 2021, the Philippine Food and Drug Administrations could approve the effective ones among them for distribution, based on their assessment of the phase three trials. From April to June 2021, the approved vaccines could be ready for local distribution.

Currently, the Department of Health is waiting for the clinical trial protocol for the vaccine called “Sputnik V” from Russia before it starts its evaluation for the conduct of clinical trials in the Philippines.

Shortened approval process time envisaged

Health officials already discussed the regulatory process with the Russian Embassy in Manila. They have committed to shorten the clearance process from 55 days to about 43 days once the requirements are complete, Vergeire said.

Besides the Russian vaccine, other candidates are vaccines developed in China, among other countries, that the Philippines will evaluate for use against the coronavirus. There is also a domestic vaccine development ongoing.

The Philippines is particularly plagued by the disease. As of September 21, the country has seen more than 290,000 infections, the most in Southeast Asia, with 230,000 recovered cases and 4,999 deaths.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

NO COMMENTS

Leave a Reply